Peripheral intravenous catheter needleless connector decontamination study—Randomized controlled trial - 26/08/20
, Marie Cooke, PhD b, c, Fiona Fullerton, MAdvanced Prac a, Michael Whitby, MD, PhD d, Jennine Hay, MCliSc (CliMicro) e, Scott Lingard, MSc (CliMicro) e, Joel Douglas, BappSc-MLS e, Claire M. Rickard, PhD b, cRésumé |
Background |
Needleless connectors (NCs) were introduced to reduce health care work needlestick injuries (NSIs). If not decontaminated prior to use, NCs can be a portal for patient blood stream infections. The optimal disinfectant, and its application duration, for NC decontamination has not been empirically established.
Methods |
Factorial design randomized controlled trial comparing 70% isopropyl alcohol (IPA) and 2% chlorhexidine gluconate (CHG) in 70% IPA for 5, 10, or 15 seconds, in adult medical patients with peripheral intravenous catheters.
Results |
At baseline, 153 of 300 NCs (51%) grew microorganisms commonly found on the skin. Decontamination was successful in 150/153 (98%). There was no significant difference in decontamination between 70% IPA or 2% CHG in 70% IPA (P = .62), or decontamination for 5, 10, or 15 seconds (P = .21).
Conclusions |
There was no difference in the effectiveness of 70% IPA and 2% CHG in 70% IPA for NC decontamination for peripheral intravenous catheters in the clinical environment. Successful decontamination was not different for applications of 5, 10, and 15 seconds; 15 seconds did not always remove all microorganisms. Factors such as cost, feasibility of compliance, and low risk of allergy support 5 seconds decontamination with 70% IPA as an acceptable approach.
Le texte complet de cet article est disponible en PDF.Highlights |
• | PIVC NC cleaning successful 98% |
• | No difference 70% IPA and 2% CHG and 70% IPA |
• | No difference 5, 10, 15 seconds decontamination |
Key Words : Blood stream infection, Microbiology
Plan
| Disclosures: Dr Cooke reports other from Baxter, grants from Becton, Dickinson and Company, Centurion Medical Products and Entrotech Lifesciences, outside the submitted work. Dr Rickard reports grants and other from 3M, grants from Angiodynamics, grants from Baxter, grants from BD-Bard, grants from Cardinal Health, grants from Medtronic, grants from Smiths Medical, other from BBraun, other from ResQDevices, outside the submitted work. |
Vol 48 - N° 9
P. 1013-1018 - septembre 2020 Retour au numéro
Article précédent
- Outpatient antimicrobial stewardship: Targets for urinary tract infections
- Bethany A. Wattengel, Sara DiTursi, Jennifer L. Schroeck, John A. Sellick, Kari A. Mergenhagen
- Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections
- Paul P. Cook, Suzy Nichols, Michael Coogan, Jackie Opera, Michelle DeHart
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?